These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 24132197)
1. An efficient and facile methodology for bromination of pyrimidine and purine nucleosides with sodium monobromoisocyanurate (SMBI). Maity J; Stromberg R Molecules; 2013 Oct; 18(10):12740-50. PubMed ID: 24132197 [TBL] [Abstract][Full Text] [Related]
2. Facile Access to Bromonucleosides Using Sodium Monobromoisocyanurate (SMBI). Maity J; Srivastava S; Sanghvi YS; Prasad AK; Stromberg R Curr Protoc Nucleic Acid Chem; 2017 Mar; 68():1.39.1-1.39.9. PubMed ID: 28252180 [TBL] [Abstract][Full Text] [Related]
3. 4'-C-methyl-beta-D-ribofuranosyl purine and pyrimidine nucleosides revisited. Griffon JF; Dukhan D; Pierra C; Benzaria S; Loi AG; La Colla P; Sommadossi JP; Gosselin G Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):707-9. PubMed ID: 14565259 [TBL] [Abstract][Full Text] [Related]
8. Fluorescent 5-Pyrimidine and 8-Purine Nucleosides Modified with an N-Unsubstituted 1,2,3-Triazol-4-yl Moiety. Wen Z; Tuttle PR; Howlader AH; Vasilyeva A; Gonzalez L; Tangar A; Lei R; Laverde EE; Liu Y; Miksovska J; Wnuk SF J Org Chem; 2019 Mar; 84(6):3624-3631. PubMed ID: 30806513 [TBL] [Abstract][Full Text] [Related]
9. Cleavage effect of oligoribonucleotides substituted at the cleavage sites with modified pyrimidine- and purine-nucleosides. Hosono K; Gozu H; Hosaka H; Sakamoto K; Yokoyama S; Takai K; Takaku H Biochim Biophys Acta; 1997 Nov; 1354(3):211-8. PubMed ID: 9427530 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-hepatitis C virus (HCV) activity of 3'-C-substituted-methyl pyrimidine and purine nucleosides. Choi WJ; Kim YM; Kim HO; Lee HW; Kim DE; Park KS; Chong Y; Jeong LS Bioorg Med Chem; 2010 Jul; 18(13):4812-20. PubMed ID: 20627592 [TBL] [Abstract][Full Text] [Related]
12. Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents. Jeong LS; Schinazi RF; Beach JW; Kim HO; Nampalli S; Shanmuganathan K; Alves AJ; McMillan A; Chu CK; Mathis R J Med Chem; 1993 Jan; 36(2):181-95. PubMed ID: 8423591 [TBL] [Abstract][Full Text] [Related]
13. The novel unsaturated acyclic nucleoside analogues: cytostatic and antiviral activity evaluations. Wittine K; Benci K; Pavelić SK; Pavelić K; Mintas M Nucleic Acids Symp Ser (Oxf); 2008; (52):601-2. PubMed ID: 18776523 [TBL] [Abstract][Full Text] [Related]
14. Development of novel PRODAN-labeled nucleosides as base-discriminating fluorescent probes. Tainaka K; Ikeda S; Tanaka K; Nishiza K; Fujiwara Y; Okamoto A; Saito I Nucleic Acids Symp Ser (Oxf); 2006; (50):133-4. PubMed ID: 17150853 [TBL] [Abstract][Full Text] [Related]
15. Abiotic synthesis of purine and pyrimidine ribonucleosides in aqueous microdroplets. Nam I; Nam HG; Zare RN Proc Natl Acad Sci U S A; 2018 Jan; 115(1):36-40. PubMed ID: 29255025 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of [(2'S, 3'S)-bis(hydroxylmethyl)pyrrolidin-1-yl] purine and pyrimidine nucleosides as potential antiviral agents. Oohashi T; Nishiyama S; Yamamura S; Kato K Bioorg Med Chem Lett; 1998 May; 8(10):1187-8. PubMed ID: 9871732 [TBL] [Abstract][Full Text] [Related]
20. Functionalization of pyrimidine and purine nucleosides at C4 and C6: C-nucleophilic substitution of their C4- and C6-(1,2,4-triazol-1-yl) derivatives. Timoshchuk V Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):1043-6. PubMed ID: 16248088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]